Skip to main content
. 2021 Jul 2;30(4):1480–1490. doi: 10.1007/s00167-021-06644-2

Table 3.

Number of injuries among players stratified into low, intermediate, and high dose of Knee Control

Low dose Intermediate dose High dose
Acute Gradual onset Acute Gradual onset Acute Gradual onset
All injuries, n 8 25 31 93 13 27
Time loss, n (%) 7 (88) 9 (36) 16 (52) 35 (38) 5 (38) 7 (26)
New injury, n (%) 7 (88) 7 (28) 23 (74) 35 (38) 10 (77) 5 (19)
Reinjury, n (%) 1 (12) 18 (72) 8 (26) 58 (62) 3 (23) 22 (81)
Injury location, n (%)
 Lower limbs 4 (50) 19 (76) 25 (81) 76 (82) 11 (85) 20 (74)
  Hip/groin 1 (13) 1 (4) 3 (10) 3 (3) 2 (15) 3 (11)
  Thigh 1 (13) 0 8 (26) 4 (4) 2 (15) 0
  Knee 1 (13) 13 (52) 7 (23) 53 (57) 1 (8) 12 (44)
  Lower leg/Achilles tendon 0 2 (8) 1 (3) 8 (9) 2 (15) 0
  Ankle 1 (13) 1 (4) 4 (13) 1 (1) 3 (23) 0
  Foot/toe 0 2 (8) 2 (6) 7 (8) 1 (8) 5 (19)
 Trunk 2 (25) 0 2 (6) 9 (10) 1 (8) 2 (7)
 Upper limbs 1 (13) 2 (8) 3 (10) 3 (3) 0 3 (11)
 Head and neck 1 (13) 0 1 (3) 1 (1) 1 (8) 2 (7)
 Other 0 0 0 1 (1) 0 0

Low dose (n = 64): < 1 Knee Control session per week, intermediate dose (n = 185): ≥ 1 to < 2 Knee Control sessions per week, high dose (n = 52): ≥ 2 Knee Control sessions per week